| 摘要 |
This invention relates to the treatment of atherosclerosis via raising the level of HDL cholesterol by administration of a compound of formula (I), wherein R<1>, R<2>, and R<3> are independently hydrogen, C1-C6 alkyl or -(CH2)0-6Ph where Ph is optionally substituted by halogen, cyano, nitro, C1-C6 alkyl, C1-C6 alkoxy, trifluoromethyl, C1-C6 alkoxycarbonyl, -CO2H or OH; R4 and R5 are independently hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, or -(CH2)0-6Ar<1> where Ar<1> is phenyl, naphthyl, furanyl, pyridinyl or thenyl and Ar<1> can be optionally substituted by halogen, cyano, nitro, C1-C6 alkyl, phenyl, C1-C6 alkoxy, phenoxy, trifluoromethyl, C1-C6 alkoxycarbonyl, -CO2H or OH; and Ar is phenyl, naphthyl, furanyl, pyridinyl or thienyl or Ar is optionally substituted by halogen, cayno, nitro, C1-C6 alkyl, phenyl, C1-C6 alkoxy, phenoxy, trifluoromethyl, C1-C6 alkoxycarbonyl, -CO2H or OH.
|
